Answer
Cisatracurium besilate requires caution in patients with myasthenia gravis because they have greatly increased sensitivity to non-depolarising blocking agents; an initial dose not exceeding 0.02 mg/kg is recommended.
Sources for this answer
- Cisatracurium 2mg/ml solution for injection/infusionAspen · emc · SmPC §4.4 Special warnings and precautions for use · Version 13Document updated
Sources checked